证明(3-4cos2A+con4A)/(3+4cos2A+cos4A)=tan^4A
来源:学生作业帮 编辑:搜搜做题作业网作业帮 分类:英语作业 时间:2024/04/28 15:46:19
证明(3-4cos2A+con4A)/(3+4cos2A+cos4A)=tan^4A
TAN-67
【化学名】(-)-(4aS*,12aR*)-4a-(3-Hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine
【CAS登记号】【结构式】
【分子式】C23-H24-N2-O
【分子量】344.4556
【原研厂家】Toray (Originator)
【作用类别】ANALGESIC AND ANESTHETIC DRUGS,Analgesic Drugs,Opioid Analgesics,delta-Opioid Agonists
【研发状态】Preclinical
【合成情况】
〖来源〗Chem Pharm Bull
〖合成路线〗
〖标题〗Rational drug design and synthesis of a highly selective nonpeptide delt-opioid agonist,(4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octrahydropyrido[3,4-b]acridine (TAN-67)
〖合成方法〗The cyclization of perhydroisoquinoline (I) with o-amino-benzaldehyde (II) in the presence of methanesulfonic acid in refluxing EtOH gave the pyridoacridine (III).Subsequent cleavage of the methyl ether function using n-PrSH and tert-BuOK in boiling DMF provided the target phenol.
〖作者〗Nagase,H.; Kawai,K.; Hayakawa,J.; Wakita,H.; Mizusuna,A.; Matsuura,H.; Tajima,C.; Takezawa,Y.; Endoh,T.
〖参考〗Nagase,H.; Kawai,K.; Hayakawa,J.; Wakita,H.; Mizusuna,A.; Matsuura,H.; Tajima,C.; Takezawa,Y.; Endoh,T.; Rational drug design and synthesis of a highly selective nonpeptide delt-opioid agonist,(4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4es/10_5_hkavynmfxxnmvbvo.html">eIǚ\x08Ꚑݐul> li>a href="/databases/10_1_vqrupomukvaqu
〖出处〗Chem Pharm Bull1998,46,(11):1695
〖备注〗The cyclization of perhydroisoquinoline (I) with o-amino-benzaldehyde (II) in the presence of methanesulfonic acid in refluxing EtOH gave the pyridoacridine (III).Subsequent cleavage of the methyl ether function using n-PrSH and tert-BuOK in boiling DMF provided the target phenol (1).
〖来源〗Symp Med Chem
〖合成路线〗
〖标题〗Rational drug design and synthesis of opioid delta-receptor selective nonpeptidic agonists - Optical resolution of TAN-67 and the pharmacological effect of each enantiomer
〖合成方法〗The cyclization of perhydroisoquinoline (I) with o-amino-benzaldehyde (II) in the presence of methanesulfonic acid in refluxing EtOH gave the pyridoacridine (III).Subsequent cleavage of the methyl ether function using n-PrSH and tert-BuOK in boiling DMF provided the target phenol.
〖作者〗Fujii,H.; et al.
〖参考〗Fujii,H.; et al.; Rational drug design and synthesis of opioid delta-receptor selective nonpeptidic agonists - Optical resolution of TAN-67 and the pharmacological effect of each enantiomer.Symp Med Chem 1999,Abst 1P-21
〖出处〗Symp Med Chem1999,():Abst 1P-21
【化学名】(-)-(4aS*,12aR*)-4a-(3-Hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine
【CAS登记号】【结构式】
【分子式】C23-H24-N2-O
【分子量】344.4556
【原研厂家】Toray (Originator)
【作用类别】ANALGESIC AND ANESTHETIC DRUGS,Analgesic Drugs,Opioid Analgesics,delta-Opioid Agonists
【研发状态】Preclinical
【合成情况】
〖来源〗Chem Pharm Bull
〖合成路线〗
〖标题〗Rational drug design and synthesis of a highly selective nonpeptide delt-opioid agonist,(4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octrahydropyrido[3,4-b]acridine (TAN-67)
〖合成方法〗The cyclization of perhydroisoquinoline (I) with o-amino-benzaldehyde (II) in the presence of methanesulfonic acid in refluxing EtOH gave the pyridoacridine (III).Subsequent cleavage of the methyl ether function using n-PrSH and tert-BuOK in boiling DMF provided the target phenol.
〖作者〗Nagase,H.; Kawai,K.; Hayakawa,J.; Wakita,H.; Mizusuna,A.; Matsuura,H.; Tajima,C.; Takezawa,Y.; Endoh,T.
〖参考〗Nagase,H.; Kawai,K.; Hayakawa,J.; Wakita,H.; Mizusuna,A.; Matsuura,H.; Tajima,C.; Takezawa,Y.; Endoh,T.; Rational drug design and synthesis of a highly selective nonpeptide delt-opioid agonist,(4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4es/10_5_hkavynmfxxnmvbvo.html">eIǚ\x08Ꚑݐul> li>a href="/databases/10_1_vqrupomukvaqu
〖出处〗Chem Pharm Bull1998,46,(11):1695
〖备注〗The cyclization of perhydroisoquinoline (I) with o-amino-benzaldehyde (II) in the presence of methanesulfonic acid in refluxing EtOH gave the pyridoacridine (III).Subsequent cleavage of the methyl ether function using n-PrSH and tert-BuOK in boiling DMF provided the target phenol (1).
〖来源〗Symp Med Chem
〖合成路线〗
〖标题〗Rational drug design and synthesis of opioid delta-receptor selective nonpeptidic agonists - Optical resolution of TAN-67 and the pharmacological effect of each enantiomer
〖合成方法〗The cyclization of perhydroisoquinoline (I) with o-amino-benzaldehyde (II) in the presence of methanesulfonic acid in refluxing EtOH gave the pyridoacridine (III).Subsequent cleavage of the methyl ether function using n-PrSH and tert-BuOK in boiling DMF provided the target phenol.
〖作者〗Fujii,H.; et al.
〖参考〗Fujii,H.; et al.; Rational drug design and synthesis of opioid delta-receptor selective nonpeptidic agonists - Optical resolution of TAN-67 and the pharmacological effect of each enantiomer.Symp Med Chem 1999,Abst 1P-21
〖出处〗Symp Med Chem1999,():Abst 1P-21
证明:(3-4cos2A+cos4A)/(3+4cos2A+cos4A)=tan四次方A 要详解
三角函数证明题(1)3+cos4a-4cos2a=8sin~4次方 a(2)tanatanb/tan2a-tana +
已知tan a=根号7 ,求cos4a-cos2a
请证明 sin4a-cos4a=sin2a-cos2a
化简[cos(4a-π/2)*sin(π/2-a)*cos2a]/[(1+cos2a)(1+cos4a)*cosa
tan(a+π/4)=3+2倍根号2,则1-cos2a/sin2a=
已知tan(a+π|4)=3+2根号2,求1-cos2a|sin2a
三角比:[cos(4a-PAI/2)*sin(PAI/2-2a)]/[(1+cos2a)*(1+cos4a)]
已知tan(4分之派+a)=2分之1,求1+cos2a分之sin2a-cos2a的值 要过程
已知a第三象限的角,cos2a= -3/5,则tan(π/4+2a)=?
已知a第三象限的角,cos2a= -3/5, 则tan(π/4+2a)=?
1.已知tan a=2/3,求sin2a-2sinacosa=4cos2a(2是平方)